Deep Tech Startups

Consumer Physics (SCiO) makes a handheld near-infrared spectroscopy scanner paired with a database of molecular signatures to analyze the chemical composition of physical materials. It provides businesses with material-analysis data and tools for measuring the makeup of physical objects.

2 investors

Continuum Powders manufactures premium metal powders for advanced manufacturing applications, including aerospace, energy, defense, and medical markets. The company supplies virgin and reclaimed metal feedstocks engineered for high-performance alloys, supply chain resilience, and circular manufacturing practices.

2 investors

Copenhagen Atomics is a Danish nuclear energy company developing thorium molten salt reactors designed for mass manufacturing, sold to nuclear power plant owners as fixed-price 100 MWth reactor units with fuel supply and maintenance. Founded in 2014 and based near Copenhagen, it has built prototype reactors and targets low-cost electricity, with its first test reactor planned for 2028.

2 investors

Copperstone Tech designs and operates HELIX robots, autonomous all-terrain vehicles equipped with sensor payloads to conduct surveys and data collection in extreme environments including mines, water bodies, and hazardous terrain while minimizing human exposure to dangerous conditions.

2 investors

CORE POWER develops nuclear energy solutions designed for deployment in hard-to-decarbonize industries that require reliable, continuous power. The company focuses on engineering, certification, and delivery of scalable nuclear systems grounded in physics and regulatory compliance.

2 investors

Corellium provides virtualized iOS, iPadOS, and Android device environments with root-level access, kernel visibility, and snapshots for security teams conducting mobile vulnerability research, malware analysis, and reverse engineering. It can be deployed via secure cloud (AWS Graviton Arm servers), on-site Arm-based server and desktop appliances, or air-gapped networks for government and regulated organizations.

2 investors

Corespan optimizes data center architecture through software-integrated AI infrastructure that dynamically allocates compute resources to workloads. The company provides vendor-agnostic deployment tools targeting organizations seeking to simplify and scale advanced AI operations.

2 investors

CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for β-thalassemia and sickle cell disease.

2 investors

Corvion develops fully implantable left ventricular assist devices (LVADs) for cardiac patients. The company focuses on improving the quality of life and survival outcomes for patients with advanced heart failure.

2 investors

Cosmos Innovation develops a machine learning platform for optimizing recipe development in semiconductor and solar process engineering. It targets manufacturers and developers of next-generation semiconductor technologies.

2 investors

Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare. The company serves medical research institutions, pharmaceutical manufacturers, and diagnostic laboratories in Japan.

2 investors

Covaron Advanced Materials develops high-performance coatings for high-heat and high-abrasion applications, including thermal coatings rated to point-source temperatures up to 1600°C and single-part spray abrasion and corrosion coatings. It serves industrial, aerospace, transportation, and defense customers.

2 investors

Crayonic develops embedded crypto-biometric technology for secure digital identity solutions, combining machine learning, cryptography, and secure microprocessors. The company serves organizations in sensitive markets requiring core digital identity protection for people and assets.

2 investors

CREAL develops light-field display technology for augmented and mixed reality, enabling full 3D visualization in XR devices such as smart glasses. Its engineering work spans optics and electronics for next-generation display and XR hardware.

2 investors

Credoxys develops high-performance chemicals used in the production and application of OLED, and works in the organic electronics field covering OLED, OPV, and organic sensing. The company is based in Dresden, Germany, a hub for organic electronics.

2 investors

Creoptix, a Malvern Panalytical brand, develops bioanalytical instruments for molecular interaction analysis, including its WAVE biosensor system for real-time kinetics and affinity studies of molecules such as small molecules, peptides, and proteins. Its tools serve drug discovery and life sciences research for both industry and academia.

2 investors

Creyon develops aptamer-delivered oligonucleotide therapeutics for targeted cell-specific delivery, including small interfering RNA and antisense oligonucleotides. The company's platform addresses limitations in tissue penetration and immunogenicity for central nervous system and other tissue-targeted applications.

2 investors

Cristal Therapeutics develops therapeutics in the life sciences sector. The page does not provide sufficient details about specific products, customer segments, or market focus to construct a fuller description.

2 investors

CRON develops senseEDGE, a deep learning-based perception software for LiDAR sensors that detects, classifies, and tracks objects in real time across varied conditions and environments. It targets applications such as intelligent transportation systems (ITS), smart spaces, and security, and supports multiple LiDAR makes and sensor setups.

2 investors

cTRL is a biotech company developing cell-based immunotherapies for cancer, drawing on expertise in the adaptive immune system, immuno-oncology, biomedical engineering, and cell therapy research and development.

2 investors

Cube Biotech develops the NativeMP™ platform, including Cubipol/SMALP copolymers and active full-length membrane protein targets, for isolating, purifying, and studying membrane proteins such as ion channels. It also offers custom protein services and bead functionalization used by research institutions for applications like antibody generation and Cryo-EM structural analysis.

2 investors

CubicSpace develops real-time adaptive playback technology that optimizes 3D, VR, and spatial content across devices ranging from glasses-free 3D displays to VR headsets like the Meta Quest 3. Its products, including CubicScreen for iPhone, aim to deliver comfortable 3D viewing without eye strain for users and immersive technology innovators.

2 investors

Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.

2 investors

Curoverse provides solutions built on Arvados, an open source computing platform for managing and processing large-scale data from terabytes to petabytes. The platform combines content-addressable storage with a containerized workflow engine and runs on major cloud providers and on premise.

2 investors